Healthcare >> CEO Interviews >> August 28, 2000
Glyn Edwards is Chief Executive Officer of Summit Therapeutics plc. Mr. Edwards was appointed to the board of directors as Chief Executive Officer in April 2012. Mr. Edwards has a wealth of experience garnered from a 30-year career in the life sciences industry, during which time he has held a number of senior executive and business development roles. Prior to joining Summit, he was Interim Chief Executive Officer of the U.K. trade body the BioIndustry Association — BIA — and Chief Executive Officer at Antisoma plc for 13 years, and Vice President of Business Development at Therapeutic Antibodies Ltd. Mr. Edwards holds a Bachelor of Science in biochemistry from Bristol University and a Master of Science in economics from the London Business School. Profile
Mr. Edwards: Antisoma is a cancer drug development company.
